The trademark application COSELA was filed by G1 Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 12, 2021, and it was registered by office on October 19, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations
Pharmaceutical preparations for use in oncology, improving outcomes from chemotherapy, and treatment of cancer
Therapeutic preparations for use in patients with cancer.